Clinical Trial Update: Effect of Dapagliflozin/Metformin XR vs Monotherapies on Anthropometric Indicators in Obesity [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing dapagliflozin/metformin XR versus monotherapies on anthropometric indicators in obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• dapagliflozin/metformin XR
• metformin XR (metformin)

Snippet

Sponsor: University of Guadalajara | Conditions: Obesity | Phase 4 | Status: UNKNOWN